Dynavax DVAX Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Dynavax DVAX

DVAX 10.26

-1.3%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (167)	10/22/2018 11:03:26 AM
From: scaram(o)uche	Read Replies (1) of 184

Andy Biotech? @AndyBiotech 5m5 minutes ago Andy Biotech Retweeted NYCDoc29 $MRK KEYNOTE-048 data in 1L HNSCC Both ORR and PFS actually worse in pembro mono arm vs. chemo even in high PD-L1 population ORR: 23% vs 30% mPFS: 3.4mo vs 5.0mo But pembro more durable responses driving OS benefit: HR=0.61 in high PD-L1 population https://pbs.twimg.com/media/DqHsHHVXgAA554t.jpg

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next